244 related articles for article (PubMed ID: 26254030)
21. Breast cancer before age 45 and oral contraceptive use: new findings.
Miller DR; Rosenberg L; Kaufman DW; Stolley P; Warshauer ME; Shapiro S
Am J Epidemiol; 1989 Feb; 129(2):269-80. PubMed ID: 2912040
[TBL] [Abstract][Full Text] [Related]
22. Use of oral contraceptives and endometrial cancer risk (Sweden).
Weiderpass E; Adami HO; Baron JA; Magnusson C; Lindgren A; Persson I
Cancer Causes Control; 1999 Aug; 10(4):277-84. PubMed ID: 10482486
[TBL] [Abstract][Full Text] [Related]
23. Oral contraceptive and IUD use and endometrial cancer: a population-based case-control study in Shanghai, China.
Tao MH; Xu WH; Zheng W; Zhang ZF; Gao YT; Ruan ZX; Cheng JR; Gao J; Xiang YB; Shu XO
Int J Cancer; 2006 Nov; 119(9):2142-7. PubMed ID: 16823853
[TBL] [Abstract][Full Text] [Related]
24. Modification of oral contraceptive relationships on breast cancer risk by selected factors among younger women.
Brinton LA; Gammon MD; Malone KE; Schoenberg JB; Daling JR; Coates RJ
Contraception; 1997 Apr; 55(4):197-203. PubMed ID: 9179450
[TBL] [Abstract][Full Text] [Related]
25. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
Gierisch JM; Coeytaux RR; Urrutia RP; Havrilesky LJ; Moorman PG; Lowery WJ; Dinan M; McBroom AJ; Hasselblad V; Sanders GD; Myers ER
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598
[TBL] [Abstract][Full Text] [Related]
26. Oral contraceptives and neoplasia of the uterine corpus.
Schlesselman JJ
Contraception; 1991 Jun; 43(6):557-79. PubMed ID: 1868733
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer.
Contraception; 1996 Sep; 54(3 Suppl):1S-106S. PubMed ID: 8899264
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2).
Cote ML; Alhajj T; Ruterbusch JJ; Bernstein L; Brinton LA; Blot WJ; Chen C; Gass M; Gaussoin S; Henderson B; Lee E; Horn-Ross PL; Kolonel LN; Kaunitz A; Liang X; Nicholson WK; Park AB; Petruzella S; Rebbeck TR; Setiawan VW; Signorello LB; Simon MS; Weiss NS; Wentzensen N; Yang HP; Zeleniuch-Jacquotte A; Olson SH
Cancer Causes Control; 2015 Feb; 26(2):287-296. PubMed ID: 25534916
[TBL] [Abstract][Full Text] [Related]
29. Oral contraceptives as related to cancer and benign lesions of the breast.
Fasal E; Paffenbarger RS
J Natl Cancer Inst; 1975 Oct; 55(4):767-73. PubMed ID: 1185801
[TBL] [Abstract][Full Text] [Related]
30. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
Lidegaard O
BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
[TBL] [Abstract][Full Text] [Related]
31. An aggregated analysis of hormonal factors and endometrial cancer risk by parity.
Schonfeld SJ; Hartge P; Pfeiffer RM; Freedman DM; Greenlee RT; Linet MS; Park Y; Schairer C; Visvanathan K; Lacey JV
Cancer; 2013 Apr; 119(7):1393-401. PubMed ID: 23280123
[TBL] [Abstract][Full Text] [Related]
32. Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study.
Beral V; Hermon C; Kay C; Hannaford P; Darby S; Reeves G
BMJ; 1999 Jan; 318(7176):96-100. PubMed ID: 9880284
[TBL] [Abstract][Full Text] [Related]
33. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
Suissa S; Blais L; Spitzer WO; Cusson J; Lewis M; Heinemann L
Contraception; 1997 Sep; 56(3):141-6. PubMed ID: 9347203
[TBL] [Abstract][Full Text] [Related]
34. Exogenous estrogen and endometrial carcinoma: case-control and incidence study.
McDonald TW; Annegers JF; O'Fallon WM; Dockerty MB; Malkasian GD; Kurland LT
Am J Obstet Gynecol; 1977 Mar; 127(6):572-80. PubMed ID: 190887
[TBL] [Abstract][Full Text] [Related]
35. Risk factors among young women with endometrial cancer: a Danish case-control study.
Parslov M; Lidegaard O; Klintorp S; Pedersen B; Jønsson L; Eriksen PS; Ottesen B
Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):23-9. PubMed ID: 10649152
[TBL] [Abstract][Full Text] [Related]
36. Oral contraceptives and breast cancer: review of the epidemiologic literature.
Thomas DB
Contraception; 1991 Jun; 43(6):597-642. PubMed ID: 1868735
[TBL] [Abstract][Full Text] [Related]
37. Oral contraceptives and breast cancer.
Brinton LA; Hoover R; Szklo M; Fraumeni JF
Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
[TBL] [Abstract][Full Text] [Related]
38. Results of oral contraceptive epidemiologic studies regarding neoplastic and cardiovascular effects.
Grimes DA
Int J Fertil; 1989; 34 Suppl():27-33. PubMed ID: 2576254
[TBL] [Abstract][Full Text] [Related]
39. Female hormone utilisation and risk of hepatocellular carcinoma.
Tavani A; Negri E; Parazzini F; Franceschi S; La Vecchia C
Br J Cancer; 1993 Mar; 67(3):635-7. PubMed ID: 8382515
[TBL] [Abstract][Full Text] [Related]
40. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies.
; Appleby P; Beral V; Berrington de González A; Colin D; Franceschi S; Goodhill A; Green J; Peto J; Plummer M; Sweetland S
Lancet; 2007 Nov; 370(9599):1609-21. PubMed ID: 17993361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
